Effect of angiotensin receptor blockers on the development of cancer: A nationwide cohort study in korea

The potential cancer risk associated with long‐term exposure to angiotensin receptor blockers (ARBs) is still unclear. We assessed the risk of incident cancer among hypertensive patients who were treated with ARBs compared with patients exposed to angiotensin‐converting enzyme inhibitors (ACEIs), wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Mi‐Hyang, Lee, Ju‐Hee, Lee, Chan Joo, Shin, Jeong‐Hun, Kang, Si Hyuck, Kwon, Chang Hee, Kim, Dae‐Hee, Kim, Woo‐hyeun, Kim, Hack Lyoung, Kim, Hyue Mee, Cho, In Jeong, Cho, Iksung, Hwang, Jinseub, Ryu, Soorack, Kang, Chaeyeong, Lee, Hae‐Young, Chung, Wook‐Jin, Ihm, Sang‐Hyun, Kim, Kwang Il, Cho, Eun Joo, Sohn, Il‐Suk, Park, Sungha, Shin, Jinho, Ryu, Sung Kee, Rhee, Moo‐Yong, Kang, Seok‐Min, Pyun, Wook Bum, Cho, Myeong‐Chan, Sung, Ki‐Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Angiotensin‐receptor Blockers and Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678844/
https://www.ncbi.nlm.nih.gov/pubmed/33492766
http://dx.doi.org/10.1111/jch.14187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678844/
https://www.ncbi.nlm.nih.gov/pubmed/33492766
http://dx.doi.org/10.1111/jch.14187

Ejemplares similares